ETFs & Mutual Funds
Jeremy Grantham’s GMO Files for First ETF to Track Quality Stocks
- QLTY will be actively managed and track quality-factor stocks
- GMO joins growing list of asset managers entering ETF industry
This article is for subscribers only.
Grantham Mayo Van Otterloo is planning to break ground in the $7.4 trillion exchange-traded fund industry.
The $59 billion Boston-based investment company co-founded by Jeremy Grantham filed an application with US regulators for its first ETF, dubbed the GMO U.S. Quality ETF, on Monday. The actively-managed fund would trade under the ticker QLTY and invest in stocks that GMO “believes to be of high quality,” the filing details.